1·The objective is to observe the crossed cerebellum diaschisis after focal cerebral ischemia and the interventional effects of ligustrazine.
目的是观察大鼠局灶性脑缺血后小脑失联络现象及中药川芎嗪的干预作用。
2·IMA is not specific for cardiac ischemia. IMA is also elevated in most patients with liver cirrhosis, acute infections and advanced cancers; all these conditions are potent producers of free radicals.
IMA并不单单存在于心肌缺血的患者，它在肝硬化，急性传染病和晚期癌症患者身上也呈现高浓度——这些疾病都能生产大量自由基。
3·If the data and models prove to be solid, physicians could soon be able to detect when a patient is at high risk of delayed ischemia.
如果数据和模型被证明是有效的，那么医生不久就能检测出病人何时患延迟缺血病的风险较大。
4·In roughly one-third of SAH victims, the blood vessels suddenly constrict, slowing the flow of oxygen-rich blood to the brain and causing a condition known as delayed ischemia.
大约有三分之一的sah患者的血管会突然收缩，减缓含有氧气的血液流向大脑的速度，造成一种称为延迟缺血的病情。
5·Nevertheless, IMA currently remains the only ischemia assay to have reached the clinical validation stage.
尽管如此，IMA目前依然是仅有的达到临床检验阶段的缺血分析方法。